| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,816 |
7,713 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,596 |
6,563 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,332 |
7,860 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,670 |
13,076 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,816 |
12,567 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,685 |
1,640 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,726 |
2,844 |
$297.90 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,153 |
6,711 |
$198.36 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
5,209 |
2,204 |
$177.14 |
| 87581 |
|
1,685 |
1,640 |
$118.07 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,551 |
1,103 |
$81.20 |
| 86684 |
|
1,684 |
1,640 |
$57.67 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
932 |
562 |
$56.25 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,885 |
2,278 |
$36.76 |
| 87500 |
|
1,844 |
908 |
$30.00 |
| 87641 |
|
923 |
907 |
$30.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
847 |
651 |
$2.28 |
| 81003 |
|
2,152 |
1,842 |
$1.76 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
953 |
568 |
$0.60 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
225 |
220 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
742 |
621 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
763 |
461 |
$0.00 |
| 0012A |
|
16 |
16 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
63 |
63 |
$0.00 |
| 87640 |
|
594 |
577 |
$0.00 |
| 91301 |
|
60 |
56 |
$0.00 |
| 86141 |
|
27 |
27 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
215 |
213 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
62 |
62 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
40 |
40 |
$0.00 |
| 0011A |
|
20 |
20 |
$0.00 |
| 82607 |
|
14 |
14 |
$0.00 |
| 80076 |
|
28 |
28 |
$0.00 |
| 87653 |
|
364 |
354 |
$0.00 |
| 87481 |
|
1,152 |
352 |
$0.00 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
18 |
18 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
586 |
475 |
$0.00 |
| 99051 |
|
214 |
212 |
$0.00 |
| 69209 |
|
37 |
37 |
$0.00 |
| 99072 |
|
78 |
78 |
$0.00 |
| 81025 |
|
166 |
112 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
17 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
18 |
18 |
$0.00 |